[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3884 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 3884

 To amend title XI of the Public Health Service Act to reauthorize the 
  program providing for sickle cell disease and other heritable blood 
      disorders research, surveillance, prevention, and treatment.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              June 7, 2023

  Mr. Burgess (for himself, Mr. Davis of Illinois, and Mr. Carter of 
   Georgia) introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend title XI of the Public Health Service Act to reauthorize the 
  program providing for sickle cell disease and other heritable blood 
      disorders research, surveillance, prevention, and treatment.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Sickle Cell Disease and Other 
Heritable Blood Disorders Research, Surveillance, Prevention, and 
Treatment Act of 2023''.

SEC. 2. REAUTHORIZATION OF SICKLE CELL DISEASE AND OTHER HERITABLE 
              BLOOD DISORDERS RESEARCH, SURVEILLANCE, PREVENTION, AND 
              TREATMENT.

    Section 1106(b)(6) of the Public Health Service Act (42 U.S.C. 
300b-5(b)(6)) is amended by striking ``2019 through 2023'' and 
inserting ``2024 through 2028''.
                                 <all>